Literature DB >> 17083104

Extradural motor cortex stimulation in Parkinson's disease.

Roberto Cilia1, Andrea Landi, Francesco Vergani, Erik Sganzerla, Gianni Pezzoli, Angelo Antonini.   

Abstract

Extradural motor cortex stimulation (EMCS) is a surgical procedure proposed for patients with advanced Parkinson's disease (PD) who cannot undergo deep brain stimulation (DBS). Five PD patients with motor fluctuations and dyskinesia underwent EMCS of the left hemisphere. All fulfilled CAPSIT criteria for DBS, with the exception of age > 70 years. Patients were assessed preoperatively and 6 months after surgery on and off medications, with stimulator on, and 2 weeks later with stimulator off. Outcome measures included changes in mean medication dosage (levodopa and dopamine agonists), Unified Parkinson's Disease Rating Scale (UPDRS Parts II-III and Item 39), and dyskinesias (Abnormal Involuntary Movements Scale [AIMS]). We found no significant mean changes following EMCS. However, there was a trend for a reduction of mean daily medication intake (-30%) and AIMS (-19%). There were 3 patients who reported reduced OFF time (UPDRS Item 39) and 4 of 5 who felt a subjective benefit in stability and gait. In our PD cohort, EMCS induced no objective benefit, although some subjective improvement was reported mostly on axial symptoms. Copyright 2006 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17083104     DOI: 10.1002/mds.21207

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

Review 1.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 2.  Neural circuit modulation during deep brain stimulation at the subthalamic nucleus for Parkinson's disease: what have we learned from neuroimaging studies?

Authors:  Daniel L Albaugh; Yen-Yu Ian Shih
Journal:  Brain Connect       Date:  2013-12-18

3.  High-frequency deep brain stimulation of the putamen improves bradykinesia in Parkinson's disease.

Authors:  Erwin B Montgomery; He Huang; Harrison C Walker; Barton L Guthrie; Ray L Watts
Journal:  Mov Disord       Date:  2011-06-28       Impact factor: 10.338

Review 4.  Motor cortex stimulation for pain and movement disorders.

Authors:  Jeffrey E Arle; Jay L Shils
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 5.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

6.  Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome.

Authors:  Carla Piano; Francesco Bove; Delia Mulas; Enrico Di Stasio; Alfonso Fasano; Anna Rita Bentivoglio; Antonio Daniele; Beatrice Cioni; Paolo Calabresi; Tommaso Tufo
Journal:  Brain Sci       Date:  2021-03-26

7.  Optical deconstruction of parkinsonian neural circuitry.

Authors:  Viviana Gradinaru; Murtaza Mogri; Kimberly R Thompson; Jaimie M Henderson; Karl Deisseroth
Journal:  Science       Date:  2009-03-19       Impact factor: 47.728

8.  Motor cortex stimulation in Parkinson's disease.

Authors:  Marisa De Rose; Giusy Guzzi; Domenico Bosco; Mary Romano; Serena Marianna Lavano; Massimiliano Plastino; Giorgio Volpentesta; Rosa Marotta; Angelo Lavano
Journal:  Neurol Res Int       Date:  2012-11-08

9.  Detecting a Cortical Fingerprint of Parkinson's Disease for Closed-Loop Neuromodulation.

Authors:  Kevin Kern; Georgios Naros; Christoph Braun; Daniel Weiss; Alireza Gharabaghi
Journal:  Front Neurosci       Date:  2016-03-30       Impact factor: 4.677

Review 10.  Deep Brain Stimulation in Parkinson's Disease: New and Emerging Targets for Refractory Motor and Nonmotor Symptoms.

Authors:  Dustin Anderson; Grayson Beecher; Fang Ba
Journal:  Parkinsons Dis       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.